Augmentation of lithium's behavioral effect by inositol uptake inhibitors

Journal of Neural Transmission

Volumn 105, Issue 1, 1998, Pages 31-38

  Einat, H ^a   Kofman, O ^b   Itkin, O ^a   Lewitan, R J ^a   Belmaker, R H ^a  

^a MENTAL HEALTH CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Bipolar disorder; Fucose; Inositol; Lithium; Nordidemnin; Uptake

Indexed keywords

FUCOSE; INOSITOL; INOSITOL MONOPHOSPHATASE; INOSITOL TRISPHOSPHATE; LITHIUM; NORDIDEMNIN; PILOCARPINE; UNCLASSIFIED DRUG;

AFFECTIVE NEUROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME INHIBITION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MANIC DEPRESSIVE PSYCHOSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SECOND MESSENGER; SEIZURE;

ANIMALS; DEPSIPEPTIDES; DRUG SYNERGISM; FUCOSE; INJECTIONS, INTRAVENTRICULAR; INOSITOL; LITHIUM; MALE; PEPTIDES, CYCLIC; PILOCARPINE; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES;

EID: 0031890731     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020050035     Document Type: Article

References (27)

1. Agam G, Belfair N, Shapiro J, Shimon H, Belmaker RH (1995) Plasma inositol levels in lithium-treated manic-depressives, schizophrenics and controls. Hum Psychopharmacol 10: 311-314
2. Aukema HM, Holub BJ (1994) Inositol and pyrroloquinoline quinone. In: Shils E, Olson JA, Shike M (eds) Modern nutrition in health and desease. Lea & Febiger, Philadelphia
3. + ions. J Neurochem 65: 2279-2289
4. Batty IH, Mitchie A, Fennel M, Downes CP (1993) The characteristics, capacity and receptor regulation of inositol uptake in 1321N1 astrocytoma cells. Biochem J 294: 49-55
5. Berridge MJ, Downes CP, Hanley MR (1982) Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem J 206: 587-595
6. Berridge MJ, Downes CP, Hanley MR (1989) Neural and developmental actions of lithium: a unifying hypothesis. Cell 59: 411-419
7. Bersudsky Y, Shapiro J, Agam G, Kofman O, Belmaker RH (1994) Behavioral evidence for the existance of two pools of cellular inositol. Eur Neuropsychopharmacol 4: 463-467
8. Dominice C, Dufour MN, Patino N, Manzoni O, Grazzini E, Jouin P, Guillon G (1994) Dual effects of nordidemnin on WRK1 cells: inhibition of phosphoinositide metabolism and cell proliferation. J Pharmacol Exp Ther 271: 107-117
9. Drummond AH (1987) Lithium and inositol lipid-linked signaling mechanisms. Trends Pharmacol Sci 8: 129-133
10. Fisher SK, Heacock AM, Agranoff BW (1992) Inositol lipids and signal transduction in the nervous system: an update. J Neurochem 58: 18-38
11. Glanville NT, Byers DM, Cook HV, Spence MW, Palmer FB (1989) Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin. Biochim Biophys Acta 1004: 169-179
12. Hallcher LM, Sherman WR (1980) The effect of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J Biol Chem 255: 10896-10901
13. Hertz L, Wolfson M, Hertz E, Agam G, Richards M, Belmaker RH (1997) Lithium-inositol interactions: synthesis, uptake, turnover. In: Honig A, Van Praag HM (eds) Depression: neurobiological psychopathological and therapeutic advances. John Wiley & Sons, New York
14. Honchar MP, Olney JW, Sherman WR (1983) Systemic cholinergic agents induce seizures and brain damage in lithium-treated rats. Science 220: 323-325
15. Johnson SC, Dahl J, Shih TL, Schedler DJ, Anderson L, Benjamin TL, Baker DC (1993) Synthesis and evaluation of 3-modiued 1D-myo-inositols as inhibitors and substrates of phosphatidylinositol synthase and inhibitors of myo-inositol uptake by cells. J Med Chem 36: 3628-3625
16. Jouin P, Poncet J, Dufour AA, Pantaloni A (1991) Antineoplastic activity of didemnin congeners: nordidemnin and modified chain analogues. J Med Chem 34: 486-491
17. Kofman O, Sherman WR, Katz V, Belmaker RH (1993) Restoration of brain myo-inositol levels in rats increases latency to lithium-pilocarpine seizures. Psychopharmacol 110: 229-234
18. Ormandy GC, Song L, Jope RS (1991) Analysis of the convulsant-potentiating effects of lithium in rats. Exp Neurol 111: 356-361
19. Patishi Y, Belmaker RH, Agam G (1996a) Effect of age, sex, steroids, brain region, and genetic strain on brain inositol monophosphatase activity. Biol Psychiatry 40: 656-659
20. Patishi Y, Lubrich B, Berger M, Kofman O, Van-Calker D, Belmaker RH (1996b) Differential uptake of myo-inositol in vivo into rat brain areas. Eur Neuropsychopharmacol 6: 73-75
21. Regan CJ (1990) The effect of lithium on inositol phosphate metabolism. In: Bach RO, Gallicchio VS (eds) Lithium and cell physiology. Springer, New York
22. Spector R, Lorenzo AV (1975) The origin of myo-inositol in brain, cerebrospinal fluid and choroid plexus. J Neurochem 25: 353-354
23. Stefani MR, Dunlap JA, Yorek MA (1992) Effect of L-fucose on proliferation and myo-inositol metabolism in cultured cerebral microvessel and aortic endothelial cells. J Cell Physiol 153: 321-331
24. Weisinger H (1991) Myo-inositol transport in mouse astroglia-rich primary cultures. J Neurochem 56: 4698-1704
25. Wolfson M, Hertz E, Hertz L, Belmaker RH (1998) Acute and chronic effects of lithium and of inositol uptake into mouse astrocytes in primary cultures. Brain Res (in press)
26. Yorek MA, Dunlap JA, Stefani MR, Davidson EP (1992) L-fucose is a potent inhibitor of myo-inositol transport and metabolism in cultured neuroblastoma cells. J Neurochem 58: 1626-1636
27. +-ATPase activity in rats maintained on L-fucose diet. Diabetes 42: 1401-1406